TET2 and myeloid neoplasm: Indeed, loss of TET2 functions by mutations or down-modulation due to various mechanisms have been identified as a common lynchpin of myeloid malignancies, as also indicated by the meta-analysis performed in the above-mentioned study (Gurnari et al., 2022).